Related Experiment Videos
Calcium antagonists and cardiovascular disorders.
Annales De Cardiologie Et D'Angeiologie
|December 1, 1984
Summary
Calcium antagonists help manage ischemic heart disease and hypertension. While some have antiarrhythmic effects, nifedipine does not, unlike verapamil and diltiazem, offering valuable cardiovascular treatment options.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Calcium antagonists are widely used for cardiovascular conditions like ischemic heart disease and hypertension.
- Their therapeutic effects and specific properties vary among different drugs within the class.
Purpose of the Study:
- To differentiate the properties of various calcium antagonists.
- To clarify their roles in specific cardiovascular diseases and clinical scenarios.
Main Methods:
- Comparative analysis of pharmacological actions.
- Review of clinical applications and evidence.
Main Results:
- Nifedipine lacks antiarrhythmic properties at clinical doses, unlike verapamil and diltiazem.
- Calcium antagonists are beneficial in certain arrhythmias and variant angina.
- Beta-adrenergic blockers serve as adjuncts in specific conditions.
Conclusions:
- Calcium antagonists offer valuable therapeutic options for selected cardiovascular patients.
- Further research is needed to define their roles in cardiopulmonary bypass, myocardial protection, hypertrophic cardiomyopathy, and pulmonary hypertension.